Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

The main purpose is to evaluate the effectiveness of the Eliquis® (apixaban) Prescriber Guide and Patient Alert Card in terms knowledge of the important identified risk of bleeding associated with Eliquis treatment communicated by the RM tools.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 March 2016.

1 Aug 2015 13 Jan 2015 1 Jan 2017 1 Jan 2017 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Perspective: Cross-Sectional
  • Sampling: Non-Probability Sample

Contacts

  • Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:

    Clinical.Trials@bms.com

  • First line of the email MUST contain NCT# and Site #.